Erratum To: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
Digestive Diseases and Sciences - United States
doi 10.1007/s10620-017-4729-1
Full Text
Open PDFAbstract
Available in full text
Date
September 7, 2017
Authors
Publisher
Springer Science and Business Media LLC